2002 Vol.20, N°6 - Suppl.28 - Table of contents

Innovative therapies for the spondyloarthritides

Guest Editors: J. Braun, D. van der Heijde, T. Pincus

Editorial

CER1385
2002,20,6,Suppl.28
Pg. 0001-0002

Free to view

Novel anti-rheumatic therapies challenge old views on ankylosing spondylitis and other spondyloarthritides
J. Braun, D. van der Heijde, T. Pincus

Full Papers

CER1386
2002,20,6,Suppl.28
Pg. 0003-0005

Free to view

Ankylosing spondylitis - The history of medical therapies
M.A. Khan

CER1387
2002,20,6,Suppl.28
Pg. 0006-0010

Free to view

Thoughts concerning the early diagnosis of ankylosing spondylitis and related diseases
M.A. Khan

CER1388
2002,20,6,Suppl.28
Pg. 0011-0015

Free to view

Ankylosing spondylitis - Cardiac manifestations
D. Lautermann, J. Braun

CER1389
2002,20,6,Suppl.28
Pg. 0016-0022

Free to view

Mortality, course of disease and prognosis of patients with ankylosing spondylitis
J. Braun, T. Pincus

CER1390
2002,20,6,Suppl.28
Pg. 0023-0026

Free to view

Socioeconomic consequences of ankylosing spondylitis
A. Boonen

CER1391
2002,20,6,Suppl.28
Pg. 0027-0033

Free to view

Psoriatic arthritis - Pathogenesis and epidemiology
D.J. Veale, O. FitzGerald

CER1392
2002,20,6,Suppl.28
Pg. 0034-0037

Free to view

Immunological basis for the use of TNFα-blocking agents in ankylosing spondylitis and immunological changes during treatment
J.X. Zou, J. Braun, J. Sieper

CER1393
2002,20,6,Suppl.28
Pg. 0038-0042

Free to view

Influence of the gut and cytokine patterns in spondyloarthropathy
D. Baeten, F. De Keyser, N. Van Damme, E.M. Veys, H. Mielants

CER1394
2002,20,6,Suppl.28
Pg. 0043-0049

Free to view

Genetics of ankylosing spondylitis
M.A. Brown, B.P. Wordsworth, J.D. Reveille

CER1395
2002,20,6,Suppl.28
Pg. 0050-0051

Free to view

Treatment of the SpA-like disease in HLA B27 transgenic animals
M. Breban, E. May

CER1396
2002,20,6,Suppl.28
Pg. 0052-0059

Free to view

No alterations of serum levels of adrenal and gonadal hormones in patients with ankylosing spondylitis
R.H. Straub, S. Struhárová, J. Schölmerich, P. Härle

CER1397
2002,20,6,Suppl.28
Pg. 0060-0064

Free to view

Physiotherapy in ankylosing spondylitis: What is the evidence ?
S. van der Linden, A. van Tubergen, A. Hidding

CER1398
2002,20,6,Suppl.28
Pg. 0065-0066

Free to view

NSAIDs in ankylosing spondylitis
C. Miceli-Richard, M. Dougados

CER1399
2002,20,6,Suppl.28
Pg. 0067-0070

Free to view

Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs
I.E. van der Horst-Bruinsma, D.O. Clegg, B.A.C. Dijkmans

CER1400
2002,20,6,Suppl.28
Pg. 0071-0075

Free to view

Disease-modifying antirheumatic drug therapy for psoriatic arthritis
C. Salvarani, F. Cantini, I. Olivieri

CER1401
2002,20,6,Suppl.28
Pg. 0076-0080

Free to view

Methotrexate in psoriatic arthritis
M. Cutolo, B. Seriolo, C. Pizzorni, C. Craviotto, A. Sulli

CER1402
2002,20,6,Suppl.28
Pg. 0081-0087

Free to view

Standard and innovative therapy of psoriasis
C.C. Geilen, C.E. Orfanos

CER1403
2002,20,6,Suppl.28
Pg. 0088-0094

Free to view

Therapy of spondylarthropathy in inflammatory bowel disease
S. Generini, G. Fiori, M. Matucci Cerinic

CER1404
2002,20,6,Suppl.28
Pg. 0095-0100

Free to view

Standard and innovative therapy of inflammatory bowel diseases
M. De Vos

CER1405
2002,20,6,Suppl.28
Pg. 0101-0105

Free to view

Surgical options in the treatment of the spinal disorders in ankylosing spondylitis
H. El Saghir, H. Boehm

CER1406
2002,20,6,Suppl.28
Pg. 0106-0110

Free to view

Infliximab in the treatment of active and severe ankylosing spondylitis
J. Brandt, J. Sieper, J. Braun

CER1407
2002,20,6,Suppl.28
Pg. 0111-0115

Free to view

The role of etanercept in ankylosing spondylitis
J.C. Davis Jr.

CER1408
2002,20,6,Suppl.28
Pg. 0116-0121

Free to view

Psoriatic arthritis: The role of tnf inhibition and the effect of its inhibition with etanercept
P. Mease

CER1409
2002,20,6,Suppl.28
Pg. 0122-0125

Free to view

Infliximab for psoriasis and psoriatic arthritis
C. Antoni, B. Manger

CER1410
2002,20,6,Suppl.28
Pg. 0126-0129

Free to view

Anti-tumour necrosis factor (TNF)-α therapy in undifferentiated spondyloarthropathy
S. Schnarr, J.G. Kuipers, H. Zeidler

CER1411
2002,20,6,Suppl.28
Pg. 0130-0134

Free to view

TNF involvement and anti-TNF therapy of reactive and unclassified arthritis
R. Meador, E. Hsia, T. Kitumnuaypong, H.R. Schumacher

CER1412
2002,20,6,Suppl.28
Pg. 0135-0136

Free to view

The dosage of infliximab in the treatment of ankylosing spondylitis: Dollars and sense
A.S. Russell, J.H. Orozco, W.P. Maksymowych

CER1413
2002,20,6,Suppl.28
Pg. 0137-0142

Free to view

TNF-α antagonists for the treatment of juvenile-onset spondyloarthritides
G. Horneff, R. Burgos-Vargas

CER1414
2002,20,6,Suppl.28
Pg. 0143-0145

Free to view

Anti-TNF therapy for eye involvement in spondyloarthropathy
J.T. Rosenbaum, J.R. Smith

CER1415
2002,20,6,Suppl.28
Pg. 0146-0151

Free to view

Anti-TNF therapy for other inflammatory conditions
Z. Tutuncu, G.J. Morgan, Jr., A. Kavanaugh

CER1416
2002,20,6,Suppl.28
Pg. 0152-0157

Free to view

Side effects of anti-TNF therapy: Current knowledge
C. Antoni, J. Braun

CER1417
2002,20,6,Suppl.28
Pg. 0158-0161

Free to view

Thalidomide in ankylosing spondylitis
F. Huang, J.C.C. Wei, M. Breban

CER1418
2002,20,6,Suppl.28
Pg. 0162-0166

Free to view

Bisphosphonates – Targeting bone in the treatment of spondyloarthritis
H. Haibel, J. Braun, W.P. Maksymowych

CER1419
2002,20,6,Suppl.28
Pg. 0167-0174

Free to view

Use of contrast enhanced magnetic resonance imaging to detect spinal inflammation in patients with spondyloarthritides
M. Bollow, C. Enzweiler, M. Taupitz, W. Golder, B. Hamm, J. Sieper, J. Braun

CER1420
2002,20,6,Suppl.28
Pg. 0175-0177

Free to view

Etanercept treatment in resistant spondyloarthropathy: Imaging, duration of effect and efficacy on reintroduction
H. Marzo-Ortega, D. McGonagle, P. Emery

CER1421
2002,20,6,Suppl.28
Pg. 0179-0184

Free to view

Imaging and scoring in ankylosing spondylitis
J. Braun, W. Golder, M. Bollow, J. Sieper, D. van der Heijde

CER1422
2002,20,6,Suppl.28
Pg. 0185-0186

Free to view

Infliximab in spondylarthropathy- Influence on bone density
E. Dernis, C. Roux, M. Breban, M. Dougados

CER1423
2002,20,6,Suppl.28
Pg. 0187

Free to view

Anti-TNF therapy and the spondyloarthritides: Who should be treated ?
J. Braun, J. Sieper